Assuring Access to State-of-the-Art Care for U.S. Minority Populations: the First 2 Years of the Minority-Based Community Clinical Oncology Program

Abstract

The MBCCOPs have demonstrated their ability to participate in clinical trials. Evaluation reveals, however, that they are emerging organizations influenced by factors endemic to the community they serve and their own structure. The MBCCOPs are confronting substantial challenges, yet they provide an important link to the overall NCI clinical trials network.